Saturday, November 2, 2019

Crestwood, Kentucky-Based Apellis Pharmaceuticals Inc's Top-Tier Executives Average Annual Pay and Employee Benefits Increase Was a Completely Off-the-Charts 134.4% For the Most Recent Year 2018

The State of Kentucky is holding its 2019 Governor's election on November 5, 2019.

Thus I think it would be helpful to research the extent of income inequality expansion in the State of Kentucky in the most recent years.

So far in my research of large US Corporations I have shown that their Top-Tier Executives have been rewarded continually with just enormous annual increases in pay and employee benefits, mostly stock equity compensation, even to the extent that the key issue to US citizens should be the huge and continuing Income Inequality Expansion which is at the core of many critical problems the US faces.

There have been many US Government laws enacted in the past two decades that have substantially increased income inequality expansion including the year after year after year of annual furtive tax extenders of predominately special interests additional tax loopholes, which both the Democratic and Republican Establishments voted for under the radar screen every year just before calendar year end, but nothing was even close to being more income inequality expanding than the Trump Tax Cuts Act.

On the other hand, the only highly effective US Government law enacted by either party in the past two decades that has substantially reduced income inequality expansion is Obamacare.

My objective is to get a better handle on just why the US has such massive continuing Income Inequality Expansion ..... it appears to be predominantly about the relative long-term annual pay and employee benefits percentage increases for the executives of a Company vs the many non-executive employees of a Company, coupled with the stock price appreciation subsequent to the time the company executives were rewarded in their pay with stock equity compensation.

In my study here of large Kentucky Companies I will be doing this research by largest stock market capitalization and thus the tenth Kentucky Company I am addressing here is Apellis Pharmaceuticals Inc which went public with an IPO in 2017.

From annual compensation information contained in Company Proxy Statement filings with the US Securities and Exchange Commission, the table below shows Apellis Pharmaceuticals Inc's Top-Tier Executives Annual Total Compensation for each of two consecutive full years of employment for the most recent two years in which Top-Tier Executive Annual Compensation was disclosed in SEC filings related to its 2017 IPO.
   
Apellis Pharmaceuticals Inc's Top-Tier Executives Average Annual Pay and Employee Benefits Increase was a Completely Off-the-Charts 134.4% per year in 2018 and 68.7% per year during the most recent two years.


FYE FYE FYE FYE
Dec Dec Dec Dec
Apellis Pharmaceuticals 2018 2017 2017 2016
Top-Tier Total Total Total Total
Executive Comp Comp Comp Comp
$ 000s $ 000s $ 000s $ 000s
Francois M.D. Ph.D. CEO       4,075       1,663       1,663       1,498
Sullivan CFO  N/A   N/A 
Deschatelets Ph.D. COO       1,862          870          870          962
Grossi M.D. Ph.D. Chief Medical Officer  N/A   N/A 
Scheibler Ph.D. Chief Innovation Officer  N/A   N/A 
 Totals        5,937       2,533       2,533       2,460
Annual % Change vs Prior Year 134.4% 3.0%
Two Year Average Per Year % Change 68.7%